Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12787)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 14, 2019 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pellino A, Riello E, Nappo F, Brignola S, Murgioni S, Djaballah SA, Lonardi S, Zagonel V, Rugge M, Loupakis F, Fassan M. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives. World J Gastroenterol 2019; 25(38): 5773-5788 [PMID: 31636471 DOI: 10.3748/wjg.v25.i38.5773] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i38/5773.htm |
| Number | Citing Articles |
| 1 |
Xiaochen Qiu, Juan Wang, Nan Zhang, Tongde Du, Lin Chen, Hongqing Xi. Estradiol cypionate inhibits proliferation and promotes apoptosis of gastric cancer by regulating AKT ubiquitination. Biomedicine & Pharmacotherapy 2023; 165: 115073 doi: 10.1016/j.biopha.2023.115073
|
| 2 |
Xue Huang, Fujian Liu, Zhiyong Jiang, Hang Guan, Qiuhong Jia. <p>CREB1 Suppresses Transcription of microRNA-186 to Promote Growth, Invasion and Epithelial–Mesenchymal Transition of Gastric Cancer Cells Through the KRT8/HIF-1α Axis</p>. Cancer Management and Research 2020; : 9097 doi: 10.2147/CMAR.S265187
|
| 3 |
Ling-Li Li, Ze Peng, Qian Hu, Li-Jun Xu, Xin Zou, Dong-Mei Huang, Ping Yi. Berberine retarded the growth of gastric cancer xenograft tumors by targeting hepatocyte nuclear factor 4α. World Journal of Gastrointestinal Oncology 2022; 14(4): 842-857 doi: 10.4251/wjgo.v14.i4.842
|
| 4 |
Ning Ma, Hui Qiao, Hanchuan Tao, Xinli Gan, Zhili Shan, Xiaomin Chen, Xiaojun Zhou. Treatment response, survival, and safety profile of camrelizumab plus apatinib regimen as third-line treatment in metastatic gastric cancer patients. Clinics and Research in Hepatology and Gastroenterology 2022; 46(7): 101962 doi: 10.1016/j.clinre.2022.101962
|
| 5 |
Wan-Su Xu, Fei Ke, Yi Xu, Yi Zheng. LINC00963 regulates gastric cancer cell proliferation, migration, and invasion through miR-146a-5p/NFE2L1 axis. World Chinese Journal of Digestology 2021; 29(13): 690 doi: 10.11569/wcjd.v29.i13.690
|
| 6 |
Chen-hui Bao, Lin Guo. Retracted: miR-27b-3p Inhibits Invasion, Migration and Epithelial-mesenchymal Transition in
Gastric Cancer by Targeting RUNX1 and Activation of the Hippo Signaling Pathway. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(5): 864 doi: 10.2174/1871520621666210707095833
|
| 7 |
Zhao Yang Wang, Wen Xiao, Yuan Zhu Jiang, Wei Dong, Xiang Wei Zhang, Lin Zhang. HN1L promotes invasion and metastasis of the esophagogastric junction adenocarcinoma. Thoracic Cancer 2021; 12(5): 650 doi: 10.1111/1759-7714.13842
|
| 8 |
Na Liu, Mengfang Liu, Shengqiao Fu, Jinglei Wang, Haowen Tang, Adamu Danbala Isah, Deyu Chen, Xu Wang. Ang2-Targeted Combination Therapy for Cancer Treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.949553
|
| 9 |
Atakan Topcu, Muhammed Mustafa Atci, Saban Secmeler, Mehmet Besiroglu, Murat Ayhan, Metin Ozkan, Oktay Bozkurt, Zuhat Urakci, Seval Ay, Caglayan Geredeli, Ayse Irem Yasin, Haci Mehmet Turk. Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer. Future Oncology 2021; 17(31): 4157 doi: 10.2217/fon-2021-0398
|
| 10 |
Elnaz Faghfuri, Mahdi Abdoli Shadbad, Amir Hossein Faghfouri, Narges Soozangar. Cellular Immunotherapy in Gastric Cancer: Adoptive Cell Therapy and Dendritic Cell-Based Vaccination. Immunotherapy 2022; 14(6): 475 doi: 10.2217/imt-2021-0285
|
| 11 |
Xiaowen Zhu, Yumin Zou, Tong Wu, Jian Ni, Qingyun Tan, Qingdong Wang, Meijia Zhang. ANP32E contributes to gastric cancer progression via NUF2 upregulation. Molecular Medicine Reports 2022; 26(3) doi: 10.3892/mmr.2022.12791
|
| 12 |
Ning Zhou, Wei Wang, Chunlei Xu, Wenyan Yu. Circular RNA PLEC acts as a sponge of microRNA-198 to promote gastric carcinoma cell resistance to paclitaxel and tumorigenesis. Pathology - Research and Practice 2021; 224: 153487 doi: 10.1016/j.prp.2021.153487
|
| 13 |
Ya-Kun Jiang, Wei Li, Ying-Yang Qiu, Meng Yue. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer. World Journal of Gastrointestinal Oncology 2024; 16(6): 2318-2334 doi: 10.4251/wjgo.v16.i6.2318
Abstract(179) |
Core Tip(189) |
Full Article(HTML)(1023)
|
Full Article with Cover (PDF)-10337K(38)
|
Audio-441K(3)
|
Peer-Review Report-231K(19)
|
Answering Reviewers-70K(17)
|
Supplementary Material-8723K(20)
|
Full Article (PDF)-10027K(62)
|
Full Article (XML)-321K(22)
|
Times Cited (0)
|
Total Visits (1894)
|
Open
|
| 14 |
Kanwal Asif, Lorenzo Memeo, Stefano Palazzolo, Yahima Frión-Herrera, Salvatore Parisi, Isabella Caligiuri, Vincenzo Canzonieri, Carlotta Granchi, Tiziano Tuccinardi, Flavio Rizzolio. STARD3: A Prospective Target for Cancer Therapy. Cancers 2021; 13(18): 4693 doi: 10.3390/cancers13184693
|
| 15 |
Zhenliang Xie, Jincheng Li, Pu Huang, Ye Zhang, Jingkuan Yang, Kangdong Liu, Yanan Jiang. Applications and Achievements of Single-Cell Sequencing in Gastrointestinal Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.905571
|
| 16 |
Shuai Kong, Shubo Tian, Zhu Wang, Yulong Shi, Jizhun Zhang, Hongqing Zhuo. Circular RNA circPFKP suppresses the proliferation and metastasis of gastric cancer cell via sponging miR-644 and regulating ADAMTSL5 expression. Bioengineered 2022; 13(5): 12326 doi: 10.1080/21655979.2022.2073001
|
| 17 |
Jiawen Hong, Yinfei Cheng, Xiaodan Gu, Weibing Xu. Prediction models for the survival in patients with intestinal-type gastric adenocarcinoma: a retrospective cohort study based on the SEER database. BMJ Open 2023; 13(4): e070803 doi: 10.1136/bmjopen-2022-070803
|
| 18 |
Matthew W Rosenbaum, Raul S Gonzalez. Targeted therapy for upper gastrointestinal tract cancer: current and future prospects. Histopathology 2021; 78(1): 148 doi: 10.1111/his.14244
|
| 19 |
Alessandra Capuano, Maddalena Vescovo, Simone Canesi, Eliana Pivetta, Roberto Doliana, Maria Grazia Nadin, Masami Yamamoto, Tetsuya Tsukamoto, Sachiyo Nomura, Emanuela Pilozzi, Antonio Palumbo, Vincenzo Canzonieri, Renato Cannizzaro, Eugenio Scanziani, Gustavo Baldassarre, Maurizio Mongiat, Paola Spessotto. The extracellular matrix protein EMILIN-1 impacts on the microenvironment by hampering gastric cancer development and progression. Gastric Cancer 2024; 27(5): 1016 doi: 10.1007/s10120-024-01528-z
|
| 20 |
Y. Chu, B. Xu, Q. Song, Q. Hu. Radiotherapy benefited the survival of patients with intestinal-type gastric adenocarcinoma: a SEER population-based study. Clinical and Translational Oncology 2021; 23(1): 164 doi: 10.1007/s12094-020-02408-5
|
| 21 |
Umme Hani, Riyaz Ali M. Osmani, Sabina Yasmin, B. H. Jaswanth Gowda, Hissana Ather, Mohammad Yousuf Ansari, Ayesha Siddiqua, Mohammed Ghazwani, Adel Al Fatease, Ali H. Alamri, Mohamed Rahamathulla, M. Yasmin Begum, Shadma Wahab. Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy. Pharmaceutics 2022; 14(8): 1576 doi: 10.3390/pharmaceutics14081576
|
| 22 |
Axel Grothey, Jean-Yves Blay, Nick Pavlakis, Takayuki Yoshino, Jordi Bruix. Evolving role of regorafenib for the treatment of advanced cancers. Cancer Treatment Reviews 2020; 86: 101993 doi: 10.1016/j.ctrv.2020.101993
|
| 23 |
Vincenza Caputo, Vincenzo De Falco, Anna Ventriglia, Vincenzo Famiglietti, Erika Martinelli, Floriana Morgillo, Giulia Martini, Carminia Maria Della Corte, Davide Ciardiello, Luca Poliero, Ferdinando De Vita, Michele Orditura, Morena Fasano, Renato Franco, Michele Caraglia, Arianna Avitabile, Roberto Scalamogna, Beatrice Marchi, Fortunato Ciardiello, Teresa Troiani, Stefania Napolitano. Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience. Therapeutic Advances in Medical Oncology 2022; 14 doi: 10.1177/17588359221096878
|
| 24 |
Mohammed Alradhi, Shuang Wen, Mohammed Safi, Abdullah Al‐danakh, Honglong Wang, Abdullah Shopit, Min Sun, Bo Fan, Xiancheng Li. Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation. Cancer Medicine 2023; 12(4): 3931 doi: 10.1002/cam4.5121
|
| 25 |
Petar Rasic, Maja Jovanovic-Tucovic, Marija Jeremic, Slavisa M Djuricic, Zorica V Vasiljevic, Maja Milickovic, Djordje Savic. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. World Journal of Gastrointestinal Oncology 2021; 13(8): 799-821 doi: 10.4251/wjgo.v13.i8.799
|
| 26 |
Zhengwo Jia, Xiaofang Tang, Xicheng Zhang, Jingen Shen, Yuanlong Sun, Lifen Qian. miR-153-3p Attenuates the Development of Gastric Cancer by Suppressing SphK2. Biochemical Genetics 2022; 60(5): 1748 doi: 10.1007/s10528-021-10166-4
|
| 27 |
Sameer Mir, Abhilash Venugopalan, Jingli Zhang, Nishanth Ulhas Nair, Manjistha Sengupta, Manakamana Khanal, Chaido Stathopoulou, Qun Jiang, Raffit Hassan. Persistence of activated anti‐mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas. Clinical and Translational Medicine 2024; 14(11) doi: 10.1002/ctm2.70057
|
| 28 |
Xianzhe Yu, Shan He, Jian Shen, Qiushi Huang, Peng Yang, Lin Huang, Dan Pu, Li Wang, Lu Li, Jinghua Liu, Zelong Liu, Lingling Zhu. Tumor vessel normalization and immunotherapy in gastric cancer. Therapeutic Advances in Medical Oncology 2022; 14 doi: 10.1177/17588359221110176
|
| 29 |
Caiyun Nie, Huifang Lv, Yingjun Liu, Beibei Chen, Weifeng Xu, Jianzheng Wang, Xiaobing Chen. Clinical Study of Sintilimab as Second-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Retrospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.741865
|
| 30 |
Gianluca Businello, Francesca Galuppini, Matteo Fassan. The impact of recent next generation sequencing and the need for a new classification in gastric cancer. Best Practice & Research Clinical Gastroenterology 2021; : 101730 doi: 10.1016/j.bpg.2021.101730
|
| 31 |
Huanqin Li, Shuai Xue, Xiaohong Zhang, Fan Li, Songhua Bei, Li Feng. CircRNA PVT1 modulated cell migration and invasion through Epithelial-Mesenchymal Transition (EMT) mediation in gastric cancer through miR-423-5p/Smad3 pathway. Regenerative Therapy 2022; 21: 25 doi: 10.1016/j.reth.2022.02.003
|
| 32 |
Sara Rocha, Afonso P Basto, Marieke E Ijsselsteijn, Sara P Teles, Maria M Azevedo, Gilza Gonçalves, Irene Gullo, Gabriela M Almeida, Joaquín J Maqueda, Marta I Oliveira, Fátima Carneiro, João T Barata, Luís Graça, Noel F C C de Miranda, Joana Carvalho, Carla Oliveira. Immunophenotype of Gastric Tumors Unveils a Pleiotropic Role of Regulatory T Cells in Tumor Development. Cancers 2021; 13(3): 421 doi: 10.3390/cancers13030421
|
| 33 |
Daniel V. Catenacci, Joseph Chao, Kei Muro, Salah Eddin Al-Batran, Samuel J. Klempner, Zev A. Wainberg, Manish A. Shah, Sun Young Rha, Atsushi Ohtsu, Astra M. Liepa, Holly Knoderer, Anindya Chatterjee, Eric Van Cutsem. Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma. The Oncologist 2021; 26(10): e1704 doi: 10.1002/onco.13907
|
| 34 |
Dominika Bębnowska, Ewelina Grywalska, Paulina Niedźwiedzka-Rystwej, Barbara Sosnowska-Pasiarska, Jolanta Smok-Kalwat, Marcin Pasiarski, Stanisław Góźdź, Jacek Roliński, Wojciech Polkowski. CAR-T Cell Therapy—An Overview of Targets in Gastric Cancer. Journal of Clinical Medicine 2020; 9(6): 1894 doi: 10.3390/jcm9061894
|
| 35 |
Ping Zhang, Xiaomeng Zhang, Na Zhu, Feifei Zhuang, Dongmei Zhou, Ping Wang, Hangjun Che. Clinical Efficacy, Survival, and Adverse Reaction Evaluation of Immune Checkpoint Inhibitor in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/6998090
|
| 36 |
Barani Karikalan, Srikumar Chakravarthi. Target Therapy and Immunotherapy for Gastric Cancer - Recent Updates. Current Cancer Therapy Reviews 2022; 18(3): 202 doi: 10.2174/1573394718666220418095954
|
| 37 |
Sara Aviles-Gaxiola, Marilyn S. Criollo-Mendoza, Melissa García-Carrasco, Erick P. Gutiérrez-Grijalva, Israel García-Aguiar, J. Basilio Heredia. Phytochemical Nanodelivery Systems as Potential Biopharmaceuticals. 2023; : 29 doi: 10.1016/B978-0-323-90390-5.00001-3
|
| 38 |
Chu-Yun Liu, Yu-Shen Yang, Kai Ye, He-fan He. Development of nomograms for predicting the survival of intestinal-type gastric adenocarcinoma patients after surgery. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44671-w
|
| 39 |
Mei Wang, Xinxin Zhao, Rong Qiu, Zheng Gong, Feng Huang, Wanjun Yu, Bo Shen, Xin Sha, Haibo Dong, Jiaying Huang, Lin Wang, Wei Zhu, Wenrong Xu. Lymph node metastasis-derived gastric cancer cells educate bone marrow-derived mesenchymal stem cells via YAP signaling activation by exosomal Wnt5a. Oncogene 2021; 40(12): 2296 doi: 10.1038/s41388-021-01722-8
|
| 40 |
Wei Bo, Xu‐Guang Wang, Min Zhang, Zhong Zhang. ZNF655 mediated by LINC01210/miR‐124‐3p axis promotes the progression of gastric cancer. The Kaohsiung Journal of Medical Sciences 2023; 39(3): 200 doi: 10.1002/kjm2.12634
|
| 41 |
Didem Tastekin, Nail Paksoy, Izzet Dogan, Ferhat Ferhatoglu, Nijat Khanmammadov, Hamza U. Bozbey, Senem Karabulut. Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience. Journal of Cancer Research and Therapeutics 2023; 19(2): 253 doi: 10.4103/jcrt.jcrt_672_22
|
| 42 |
Gianluca Businello, Valentina Angerilli, Sara Lonardi, Francesca Bergamo, Michele Valmasoni, Fabio Farinati, Edoardo Savarino, Gaya Spolverato, Matteo Fassan. Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter. Updates in Surgery 2023; 75(2): 291 doi: 10.1007/s13304-022-01330-5
|
| 43 |
Magdalena Tyczyńska, Paweł Kędzierawski, Kaja Karakuła, Jacek Januszewski, Krzysztof Kozak, Monika Sitarz, Alicja Forma. Treatment Strategies of Gastric Cancer—Molecular Targets for Anti-angiogenic Therapy: a State-of-the-art Review. Journal of Gastrointestinal Cancer 2021; 52(2): 476 doi: 10.1007/s12029-021-00629-7
|
| 44 |
Xiaojing Chang, Xiaohui Ge, Yufeng Zhang, Xiaoying Xue. The current management and biomarkers of immunotherapy in advanced gastric cancer. Medicine 2022; 101(21): e29304 doi: 10.1097/MD.0000000000029304
|
| 45 |
Lin Li, Xiaosheng Wang. Identification of gastric cancer subtypes based on pathway clustering. npj Precision Oncology 2021; 5(1) doi: 10.1038/s41698-021-00186-z
|
| 46 |
J. Deng, W. Zhang, M. Xu, X. Liu, T. Ren, S. Li, Q. Sun, C. Xue, J. Zhou. Value of spectral CT parameters in predicting the efficacy of neoadjuvant chemotherapy for gastric cancer. Clinical Radiology 2024; 79(1): 51 doi: 10.1016/j.crad.2023.08.023
|
| 47 |
Juan Qu, Jizhi Yang, Ming Chen, Rongna Wei, Jingjing Tian. <p>CircFLNA Acts as a Sponge of miR-646 to Facilitate the Proliferation, Metastasis, Glycolysis, and Apoptosis Inhibition of Gastric Cancer by Targeting PFKFB2</p>. Cancer Management and Research 2020; : 8093 doi: 10.2147/CMAR.S264674
|
| 48 |
Osamu Toyoshima, Shuntaro Yoshida, Toshihiro Nishizawa, Akira Toyoshima, Kosuke Sakitani, Tatsuya Matsuno, Tomoharu Yamada, Takashi Matsuo, Hayato Nakagawa, Kazuhiko Koike. Enlarged folds on endoscopic gastritis as a predictor for submucosal invasion of gastric cancers. World Journal of Gastrointestinal Endoscopy 2021; 13(9): 426-436 doi: 10.4253/wjge.v13.i9.426
|
| 49 |
Meiting Chen, Kai Yao, Manming Cao, Hao Liu, Cong Xue, Tao Qin, Lingru Meng, Zhousan Zheng, Zike Qin, Fangjian Zhou, Zhuowei Liu, Yanxia Shi, Xin An. HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study. Cancer Immunology, Immunotherapy 2023; 72(7): 2309 doi: 10.1007/s00262-023-03419-1
|
| 50 |
Peter J. Choi, Thomas I−H. Park, Elizabeth Cooper, Mike Dragunow, William A. Denny, Jiney Jose. Heptamethine Cyanine Dye Mediated Drug Delivery: Hype or Hope. Bioconjugate Chemistry 2020; 31(7): 1724 doi: 10.1021/acs.bioconjchem.0c00302
|
| 51 |
Kosuke Kawagoe, Masumi Wada, Tetsuya Idichi, Reona Okada, Yasutaka Yamada, Shogo Moriya, Keishi Okubo, Daisuke Matsushita, Takaaki Arigami, Hiroshi Kurahara, Kosei Maemura, Shoji Natsugoe, Naohiko Seki. Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer. Journal of Human Genetics 2020; 65(8): 647 doi: 10.1038/s10038-020-0746-6
|
| 52 |
Matteo Fassan, Aldo Scarpa, Andrea Remo, Giovanna De Maglio, Giancarlo Troncone, Antonio Marchetti, Claudio Doglioni, Giuseppe Ingravallo, Giuseppe Perrone, Paola Parente, Claudio Luchini, Luca Mastracci. Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice. Pathologica 2020; 112(3): 248 doi: 10.32074/1591-951X-158
|
| 53 |
Irene Pecora, Clara Ugolini, Riccardo Giannini, Mirella Giordano, Caterina Vivaldi, Monica Lencioni, Stefano Santi, Valentina Massa, Giovanni Pallabazzer, Silvia Catanese, Francesca Salani, Mario Antonio Belluomini, Enrico Vasile, Chiara Cremolini, Gabriella Fontanini, Gianluca Masi, Lorenzo Fornaro. Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy. Oncology 2023; 101(7): 435 doi: 10.1159/000530853
|
| 54 |
Sai-Fung Chung, Suet-Ying Tam, Chi-Fai Kim, Hiu-Chi Chong, Leo Man-Yuen Lee, Yun-Chung Leung. Mono-PEGylated thermostable Bacillus caldovelox arginase mutant (BCA-M-PEG20) induces apoptosis, autophagy, cell cycle arrest and growth inhibition in gastric cancer cells. Investigational New Drugs 2022; 40(5): 895 doi: 10.1007/s10637-022-01265-z
|
| 55 |
Matteo Fassan, Takeshi Kuwata, Kristina A. Matkowskyj, Christoph Röcken, Josef Rüschoff. Claudin-18.2 Immunohistochemical Evaluation in Gastric and Gastroesophageal Junction Adenocarcinomas to Direct Targeted Therapy: A Practical Approach. Modern Pathology 2024; 37(11): 100589 doi: 10.1016/j.modpat.2024.100589
|
| 56 |
Antonio Pellino, Stefano Brignola, Erika Riello, Monia Niero, Sabina Murgioni, Maria Guido, Floriana Nappo, Gianluca Businello, Marta Sbaraglia, Francesca Bergamo, Gaya Spolverato, Salvatore Pucciarelli, Stefano Merigliano, Pierluigi Pilati, Francesco Cavallin, Stefano Realdon, Fabio Farinati, Angelo Paolo Dei Tos, Vittorina Zagonel, Sara Lonardi, Fotios Loupakis, Matteo Fassan. Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas. Journal of Personalized Medicine 2021; 11(11): 1095 doi: 10.3390/jpm11111095
|
| 57 |
Zhuo-Yuan Chen, Shang-Xing Sun, Si-Xian Zhu, Jie Bu, Somchai Chutipongtanate. Identification of the Roles of Chromobox Family Members in Gastric Cancer: A Study Based on Multiple Datasets. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5306509
|
| 58 |
Chengguo Li, Qian Shen, Peng Zhang, Tao Wang, Weizhen Liu, Ruidong Li, Xianxiong Ma, Xiangyu Zeng, Yuping Yin, Kaixiong Tao. Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS/STING signaling in gastric cancer cells. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-02120-4
|
| 59 |
Emerson Lucena da Silva, Felipe Pantoja Mesquita, Adrhyann Jullyanne de Sousa Portilho, Emanuel Cintra Austregésilo Bezerra, Julio Paulino Daniel, Elenn Suzany Pereira Aranha, Sarah Farran, Marne Carvalho de Vasconcellos, Maria Elisabete Amaral de Moraes, Caroline Aquino Moreira-Nunes, Raquel Carvalho Montenegro. Differences in glucose concentration shows new perspectives in gastric cancer metabolism. Toxicology in Vitro 2022; 82: 105357 doi: 10.1016/j.tiv.2022.105357
|
| 60 |
Minseok Choi, SeongRyeol Moon, Hyo Jin Eom, Seung Mook Lim, Yon Hui Kim, Seungyoon Nam. High Expression of PRNP Predicts Poor Prognosis in Korean Patients with Gastric Cancer. Cancers 2022; 14(13): 3173 doi: 10.3390/cancers14133173
|
| 61 |
Hyunjin Kim, Soomin Ahn, Won Ki Kang, Jung Yong Hong, Kyoung-Mee Kim. Two Gastric Cancers With Uncommon ALK Fusion Diagnosed With Comprehensive Panel Sequencing and Confirmed With Companion Diagnostic Assay. AJSP: Reviews and Reports 2022; 27(1): 9 doi: 10.1097/PCR.0000000000000480
|
| 62 |
Yu Hu, Ying Zhang, Meng Ding, Ruisi Xu. Long noncoding RNA TMPO‐AS1/miR‐126‐5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway. Journal of Gastroenterology and Hepatology 2021; 36(7): 1877 doi: 10.1111/jgh.15362
|
| 63 |
Yoon Ju Jung, Jin Seok Woo, Sun-Hee Hwang, SeungCheon Yang, So Jung Kim, JooYeon Jhun, Seung Yoon Lee, Kun Hee Lee, Mi-La Cho, Kyo Young Song. Effect of IL-10-producing B cells in peripheral blood and tumor tissue on gastric cancer. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01174-5
|
| 64 |
Mahdieh Razmi, Roya Ghods, Somayeh Vafaei, Maryam Sahlolbei, Leili Saeednejad Zanjani, Zahra Madjd. Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01840-z
|
| 65 |
Katia De Marco, Martina Lepore Signorile, Elisabetta Di Nicola, Paola Sanese, Candida Fasano, Giovanna Forte, Vittoria Disciglio, Antonino Pantaleo, Greta Varchi, Alberto Del Rio, Valentina Grossi, Cristiano Simone. SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer. Cells 2023; 12(20): 2481 doi: 10.3390/cells12202481
|
| 66 |
Xiao Liang, Jiamin Zhu, Yuanye Li, Yiren Xu, Kai Chen, Liting Lv, Weidong Mao. Treatment Strategies for Metastatic Gastric Cancer: Chemotherapy, Palliative Surgery or Radiotherapy?. Future Oncology 2020; 16(5): 91 doi: 10.2217/fon-2019-0495
|